Funds holding Centessa Pharmaceuticals PLC
ISIN US1523091007 · United Kingdom · LEI 213800GIDAARDSKOI827
- Fund holders
- 13
- Of which ETFs
- 5 8 other funds
- Value held
- 49.9M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 518,600 | 20.6M $ | 2.44 % | as of May 31, 2026 ↗ |
| GMO Alternative Allocation Fund GMO TRUST | 399,386 | 15.9M $ | 1.95 % | as of May 31, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 151,000 | 6M $ | 0.02 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 72,857 | 2.9M $ | 0.01 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust | 35,499 | 1.4M $ | 0.01 % | as of May 31, 2026 ↗ |
| Global Multi-Strategy Fund Principal Funds, Inc | 28,000 | 1.1M $ | 0.20 % | as of May 31, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 12,500 | 497K $ | 0.99 % | as of May 31, 2026 ↗ |
| Fidelity Puritan K6 Fund Fidelity Puritan Trust | 10,706 | 425.7K $ | 0.02 % | as of May 31, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 9,200 | 365.8K $ | 2.30 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 6,401 | 254.5K $ | 0.38 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,423 | 175.9K $ | 0.24 % | as of May 31, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 3,000 | 119.3K $ | 0.97 % | as of May 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 2,392 | 95.1K $ | 0.01 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| THE ARBITRAGE FUND ARBITRAGE FUNDS | 2.44 % | as of May 31, 2026 ↗ |
| ProShares Merger ETF ProShares Trust | 2.30 % | as of May 31, 2026 ↗ |
| GMO Alternative Allocation Fund GMO TRUST | 1.95 % | as of May 31, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 0.99 % | as of May 31, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 0.97 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.38 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 0.24 % | as of May 31, 2026 ↗ |
| Global Multi-Strategy Fund Principal Funds, Inc | 0.20 % | as of May 31, 2026 ↗ |
| Fidelity Puritan K6 Fund Fidelity Puritan Trust | 0.02 % | as of May 31, 2026 ↗ |
| Fidelity Puritan Fund Fidelity Puritan Trust | 0.02 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 13 | -55 | 1,253,964 | -93.8 % |
| 2026Q2 | 68 | +2 | 20,256,039 | +6.4 % |
| 2026Q1 | 66 | +8 | 19,036,743 | +21.0 % |
| 2025Q4 | 58 | +11 | 15,729,308 | +12.5 % |
| 2025Q3 | 47 | 0 | 13,981,177 | +11.5 % |
| 2025Q2 | 47 | +2 | 12,543,849 | -6.6 % |
| 2025Q1 | 45 | +5 | 13,428,989 | +11.7 % |
| 2024Q4 | 40 | +16 | 12,027,494 | +48.7 % |
| 2024Q3 | 24 | 0 | 8,087,773 | +14.2 % |
| 2024Q2 | 24 | +6 | 7,080,116 | +9.4 % |
| 2024Q1 | 18 | +1 | 6,468,895 | +4.0 % |
| 2023Q4 | 17 | 6,221,961 |
Institutional managers
160 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | 792.9M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 11,430,455 | 454M $ | as of Mar 31, 2026 |
| Index Venture Life Associates VI Ltd | 9,961,789 | 395.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8,925,010 | 354.5M $ | as of Mar 31, 2026 |
| Pentwater Capital Management LP | 8,170,000 | 324.5M $ | as of Mar 31, 2026 |
| FMR LLC | 6,852,047 | 272.2M $ | as of Mar 31, 2026 |
| EcoR1 Capital, LLC | 6,000,000 | 238.3M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 5,258,903 | 208.9M $ | as of Mar 31, 2026 |
| Capital World Investors | 4,832,548 | 191.9M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 4,809,000 | 191M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 4,286,480 | 170.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 4,268,353 | 169.5M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 3,574,048 | 142M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 3,492,977 | 138.7M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 3,158,041 | 125.4M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 2,125,000 | 84.4M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 2,054,175 | 81.6M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 2,049,439 | 81.4M $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,986,768 | 78.9M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,932,406 | 76.8M $ | as of Mar 31, 2026 |
| MAVERICK CAPITAL LTD | 1,854,488 | 73.7M $ | as of Mar 31, 2026 |
| First Light Asset Management, LLC | 1,560,991 | 62M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 1,400,000 | 55.6M $ | as of Mar 31, 2026 |
| Foresite Capital Management VI LLC | 1,364,019 | 54.2M $ | as of Mar 31, 2026 |
| GENERAL ATLANTIC, L.P. | 1,354,830 | 53.8M $ | as of Mar 31, 2026 |
Declared shareholders of Centessa Pharmaceuticals PLC
There are 5 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Adage Capital Management, L.P. and 2 others | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 0.00 % | 1,800 | as of Jun 30, 2026 · SCHEDULE 13G |
| INDEX VENTURES LIFE VI (JERSEY) L.P. and 2 others | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
| Medicxi Growth I LP and 9 others | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
| Pentwater Capital Management LP and 1 other | 0.00 % | 0 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Centessa Pharmaceuticals PLC". https://titelia.com/en/stocks/centessa-pharmaceuticals-plc-US1523091007